Cargando…
Integrated Models of Care for Individuals with Opioid Use Disorder: How Do We Prevent HIV and HCV?
PURPOSE OF REVIEW: To describe models of integrated and co-located care for opioid use disorder (OUD), hepatitis C (HCV), and HIV. RECENT FINDINGS: The design and scale-up of multidisciplinary care models that engage, retain, and treat individuals with HIV, HCV, and OUD are critical to preventing co...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6003996/ https://www.ncbi.nlm.nih.gov/pubmed/29774442 http://dx.doi.org/10.1007/s11904-018-0396-x |
_version_ | 1783332443475935232 |
---|---|
author | Rich, Katherine M. Bia, Joshua Altice, Frederick L. Feinberg, Judith |
author_facet | Rich, Katherine M. Bia, Joshua Altice, Frederick L. Feinberg, Judith |
author_sort | Rich, Katherine M. |
collection | PubMed |
description | PURPOSE OF REVIEW: To describe models of integrated and co-located care for opioid use disorder (OUD), hepatitis C (HCV), and HIV. RECENT FINDINGS: The design and scale-up of multidisciplinary care models that engage, retain, and treat individuals with HIV, HCV, and OUD are critical to preventing continued spread of HIV and HCV. We identified 17 models within primary care (N = 3), HIV specialty care (N = 5), opioid treatment programs (N = 6), transitional clinics (N = 2), and community-based harm reduction programs (N = 1), as well as two emerging models. SUMMARY: Key components of such models are the provision of (1) medication-assisted treatment for OUD, (2) HIV and HCV treatment, (3) HIV pre-exposure prophylaxis, and (4) behavioral health services. Research is needed to understand differences in effectiveness between co-located and fully integrated care, combat the deleterious racial and ethnic legacies of the “War on Drugs,” and inform the delivery of psychiatric care. Increased access to harm reduction services is crucial. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s11904-018-0396-x) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6003996 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-60039962018-07-02 Integrated Models of Care for Individuals with Opioid Use Disorder: How Do We Prevent HIV and HCV? Rich, Katherine M. Bia, Joshua Altice, Frederick L. Feinberg, Judith Curr HIV/AIDS Rep The Global Epidemic (SH Vermund, Section Editor) PURPOSE OF REVIEW: To describe models of integrated and co-located care for opioid use disorder (OUD), hepatitis C (HCV), and HIV. RECENT FINDINGS: The design and scale-up of multidisciplinary care models that engage, retain, and treat individuals with HIV, HCV, and OUD are critical to preventing continued spread of HIV and HCV. We identified 17 models within primary care (N = 3), HIV specialty care (N = 5), opioid treatment programs (N = 6), transitional clinics (N = 2), and community-based harm reduction programs (N = 1), as well as two emerging models. SUMMARY: Key components of such models are the provision of (1) medication-assisted treatment for OUD, (2) HIV and HCV treatment, (3) HIV pre-exposure prophylaxis, and (4) behavioral health services. Research is needed to understand differences in effectiveness between co-located and fully integrated care, combat the deleterious racial and ethnic legacies of the “War on Drugs,” and inform the delivery of psychiatric care. Increased access to harm reduction services is crucial. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s11904-018-0396-x) contains supplementary material, which is available to authorized users. Springer US 2018-05-17 2018 /pmc/articles/PMC6003996/ /pubmed/29774442 http://dx.doi.org/10.1007/s11904-018-0396-x Text en © The Author(s) 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | The Global Epidemic (SH Vermund, Section Editor) Rich, Katherine M. Bia, Joshua Altice, Frederick L. Feinberg, Judith Integrated Models of Care for Individuals with Opioid Use Disorder: How Do We Prevent HIV and HCV? |
title | Integrated Models of Care for Individuals with Opioid Use Disorder: How Do We Prevent HIV and HCV? |
title_full | Integrated Models of Care for Individuals with Opioid Use Disorder: How Do We Prevent HIV and HCV? |
title_fullStr | Integrated Models of Care for Individuals with Opioid Use Disorder: How Do We Prevent HIV and HCV? |
title_full_unstemmed | Integrated Models of Care for Individuals with Opioid Use Disorder: How Do We Prevent HIV and HCV? |
title_short | Integrated Models of Care for Individuals with Opioid Use Disorder: How Do We Prevent HIV and HCV? |
title_sort | integrated models of care for individuals with opioid use disorder: how do we prevent hiv and hcv? |
topic | The Global Epidemic (SH Vermund, Section Editor) |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6003996/ https://www.ncbi.nlm.nih.gov/pubmed/29774442 http://dx.doi.org/10.1007/s11904-018-0396-x |
work_keys_str_mv | AT richkatherinem integratedmodelsofcareforindividualswithopioidusedisorderhowdowepreventhivandhcv AT biajoshua integratedmodelsofcareforindividualswithopioidusedisorderhowdowepreventhivandhcv AT alticefrederickl integratedmodelsofcareforindividualswithopioidusedisorderhowdowepreventhivandhcv AT feinbergjudith integratedmodelsofcareforindividualswithopioidusedisorderhowdowepreventhivandhcv |